Chuan-Shu Chen

522 total citations
52 papers, 339 citations indexed

About

Chuan-Shu Chen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Chuan-Shu Chen has authored 52 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Chuan-Shu Chen's work include Prostate Cancer Treatment and Research (19 papers), Bladder and Urothelial Cancer Treatments (16 papers) and Urinary and Genital Oncology Studies (11 papers). Chuan-Shu Chen is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Bladder and Urothelial Cancer Treatments (16 papers) and Urinary and Genital Oncology Studies (11 papers). Chuan-Shu Chen collaborates with scholars based in Taiwan and China. Chuan-Shu Chen's co-authors include Chen‐Li Cheng, Shian‐Shiang Wang, Jian‐Ri Li, Kun‐Yuan Chiu, Yen‐Chuan Ou, Sheng-Chun Hung, Shun‐Fa Yang, Chia‐Yen Lin, Hao‐Chung Ho and Cheng‐Kuang Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Chuan-Shu Chen

46 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chuan-Shu Chen Taiwan	12	146	141	96	78	54	52	339
Tomokazu Sazuka Japan	11	177 1.2×	117 0.8×	111 1.2×	55 0.7×	72 1.3×	61	384
Zhenlei Zha China	11	264 1.8×	88 0.6×	121 1.3×	93 1.2×	64 1.2×	19	423
Joshua T. Phillips United Kingdom	11	234 1.6×	202 1.4×	122 1.3×	118 1.5×	64 1.2×	16	450
Arturo Mendoza-Valdés Mexico	4	170 1.2×	80 0.6×	59 0.6×	60 0.8×	67 1.2×	9	307
H. S. Levin United States	9	181 1.2×	133 0.9×	107 1.1×	38 0.5×	84 1.6×	15	396
Shaopeng Qiu China	10	78 0.5×	149 1.1×	59 0.6×	65 0.8×	38 0.7×	24	297
Fred Saad Canada	5	248 1.7×	74 0.5×	48 0.5×	84 1.1×	67 1.2×	15	333
Danilo Bottero Italy	13	297 2.0×	98 0.7×	121 1.3×	92 1.2×	54 1.0×	25	461
Faruk Özcan Türkiye	11	133 0.9×	96 0.7×	148 1.5×	27 0.3×	43 0.8×	39	308
Fengbin Gao China	10	77 0.5×	136 1.0×	110 1.1×	94 1.2×	65 1.2×	17	332

Countries citing papers authored by Chuan-Shu Chen

Since Specialization

Citations

This map shows the geographic impact of Chuan-Shu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan-Shu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan-Shu Chen more than expected).

Fields of papers citing papers by Chuan-Shu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan-Shu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan-Shu Chen. The network helps show where Chuan-Shu Chen may publish in the future.

Co-authorship network of co-authors of Chuan-Shu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan-Shu Chen. A scholar is included among the top collaborators of Chuan-Shu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan-Shu Chen. Chuan-Shu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Chia‐Yen, Chunli Wang, Cheng‐Kuang Yang, et al.. (2024). The impact of novel hormonal agents on fracture risk in prostate cancer patients: a nationwide population-based cohort study. Scientific Reports. 14(1). 26696–26696.

Chiu, Kun‐Yuan, et al.. (2024). Predictors of Failed Outcomes in Ureteral Reconstruction: A Real-World Retrospective Study. Medicina. 60(10). 1672–1672. 1 indexed citations

Chen, Chuan-Shu, et al.. (2024). Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients. PLoS ONE. 19(9). e0309941–e0309941. 1 indexed citations

Yang, Cheng‐Kuang, Jian‐Ri Li, Chuan-Shu Chen, et al.. (2024). Comparative analysis of novel hormonal agents in non-metastatic castration-resistant prostate cancer: A Taiwanese perspective. PLoS ONE. 19(8). e0306900–e0306900. 1 indexed citations

Yang, Liyu, Jian‐Ri Li, Chuan-Shu Chen, et al.. (2024). Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer. Frontiers in Pharmacology. 15. 1281654–1281654. 1 indexed citations

Yang, Chi‐Rei, Yen‐Chuan Ou, Chen‐Li Cheng, et al.. (2023). Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer. Oncology Letters. 26(1). 284–284. 2 indexed citations

Li, Jian‐Ri, Shian‐Shiang Wang, Chuan-Shu Chen, et al.. (2023). Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study. PLoS ONE. 18(1). e0279981–e0279981. 8 indexed citations

Chang, Li‐Wen, Sheng-Chun Hung, Chia‐Yen Lin, et al.. (2023). Nephroscope-assisted single-trocar insertion of peritoneal dialysis catheter prolongs the usage period of catheter compared with laparoscopic technique: Ten-year experience of a single-center. Asian Journal of Surgery. 47(1). 303–309.

Li, Jian‐Ri, Shian‐Shiang Wang, Cheng‐Kuang Yang, et al.. (2023). Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study. Anticancer Research. 43(4). 1809–1816. 2 indexed citations

10.

Chen, Chuan-Shu, Chia‐Yen Lin, Chunli Wang, et al.. (2020). Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage. Urologic Oncology Seminars and Original Investigations. 39(2). 132.e13–132.e26. 3 indexed citations

11.

Lin, Chia‐Yen, Shian‐Shiang Wang, Cheng‐Kuang Yang, et al.. (2019). Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy. Urologic Oncology Seminars and Original Investigations. 37(11). 814.e9–814.e16. 13 indexed citations

12.

Hung, Sheng-Chun, Shian‐Shiang Wang, Jian‐Ri Li, et al.. (2019). Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Urologic Oncology Seminars and Original Investigations. 37(9). 573.e9–573.e17. 9 indexed citations

13.

Hung, Sheng-Chun, Ying‐Erh Chou, Jian‐Ri Li, et al.. (2019). Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Urologic Oncology Seminars and Original Investigations. 38(2). 41.e1–41.e9. 5 indexed citations

14.

Chang, Li‐Wen, Sheng-Chun Hung, Shian‐Shiang Wang, et al.. (2019). Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center Experience. Anticancer Research. 39(7). 3901–3908. 12 indexed citations

15.

Hung, Sheng-Chun, Shian‐Shiang Wang, Jian‐Ri Li, et al.. (2018). Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics. International Journal of Medical Sciences. 15(14). 1731–1736. 12 indexed citations

16.

Hung, Sheng-Chun, Kun‐Yuan Chiu, Chen‐Li Cheng, et al.. (2017). Ureteroscopy-Assisted Laparoscopic Segmental Resection of Ureteral Stricture with a Modified Flank Position: Clinical Experience. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(7). 691–695. 2 indexed citations

17.

Lin, Chia‐Yen, Chi‐Rei Yang, Chen‐Li Cheng, et al.. (2014). Application in robotic urologic surgery. Journal of the Chinese Medical Association. 77(5). 242–245. 8 indexed citations

18.

Wang, Shian‐Shiang, Ming‐Ju Hsieh, Yen‐Chuan Ou, et al.. (2014). Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan. Tumor Biology. 35(8). 7483–7490. 8 indexed citations

19.

Wang, Shian‐Shiang, Yu‐Fan Liu, Yen‐Chuan Ou, et al.. (2013). Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan. PLoS ONE. 8(12). e82804–e82804. 13 indexed citations

20.

Chen, Chuan-Shu & Chen‐Li Cheng. (2006). Nephrogenic Adenoma of the Urinary Bladder: Clinical Experience and Review of the Literature. Journal of the Chinese Medical Association. 69(4). 166–168. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact